HSI1 26,282.79 -9.05 40.57B
HSCEI1 10,155.59 +46.44 11.16B
Back    Zoom +    Zoom - Block Traded
Citi: CN's Centralized Drug Procurement Helps Industry Consolidation, Favors Pharma Leaders in Near Term
2019-07-15 14:36:08
Citigroup in its report cited Chinese media that National Healthcare Security Administration had on 12 July called a meeting with corporate attendance, proposing updated rules and expansion of centralized procurement. Drugs that partook in the first round (December 2018) will tender again at end-2019.

The broker opined that this move should accelerate industry consolidation next year, which favors the stock prices of domestic pharma leaders in a short run.
~



AAStocks Financial News
Web Site: www.aastocks.com